4.7 Article

Overview of human 20 alpha-hydroxysteroid dehydrogenase (AKR1C1): Functions, regulation, and structural insights of inhibitors

Journal

CHEMICO-BIOLOGICAL INTERACTIONS
Volume 351, Issue -, Pages -

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.cbi.2021.109746

Keywords

AKR1C1; Hormone metabolism; Drug resistance; AKR1C1 inhibitors

Funding

  1. National Natural Science Foundation of China [81573281, 81830105, 82173652, 81973207]

Ask authors/readers for more resources

This article provides an overview of the physiological and pathological functions of human aldo-keto reductase family 1C1 (AKR1C1) and its relationship with diseases. It also summarizes the development of AKR1C1 inhibitors and the interaction between inhibitors and AKR1C1. Furthermore, it discusses the design ideals of selective AKR1C1 inhibitors and the prospects of AKR1C1 in disease treatment.
Human aldo-keto reductase family 1C1 (AKR1C1) is an important enzyme involved in human hormone metabolism, which is mainly responsible for the metabolism of progesterone in the human body. AKR1C1 is highly expressed and has an important relationship with the occurrence and development of various diseases, especially some cancers related to hormone metabolism. Nowadays, many inhibitors against AKR1C1 have been discovered, including some synthetic compounds and natural products, which have certain inhibitory activity against AKR1C1 at the target level. Here we briefly reviewed the physiological and pathological functions of AKR1C1 and the relationship with the disease, and then summarized the development of AKR1C1 inhibitors, elucidated the interaction between inhibitors and AKR1C1 through molecular docking results and existing co-crystal structures. Finally, we discussed the design ideals of selective AKR1C1 inhibitors from the perspective of AKR1C1 structure, discussed the prospects of AKR1C1 in the treatment of human diseases in terms of biomarkers, pre-receptor regulation and single nucleotide polymorphisms, aiming to provide new ideas for drug research targeting AKR1C1.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available